Explore
Validate
LearnHPA013411
antibody from Atlas Antibodies
Targeting: PDCD1LG2
B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA013411 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA013411, RRID:AB_1855102
- Product name
- Anti-PDCD1LG2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human PDCD1LG2, Gene description: programmed cell death 1 ligand 2, Alternative Gene Names: B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2, Validated applications: ICC, IHC, Uniprot ID: Q9BQ51, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Chervoneva I, Peck A, Sun Y, Yi M, Udhane S, Langenheim J, Girondo M, Jorns J, Chaudhary L, Kamaraju S, Bergom C, Flister M, Hooke J, Kovatich A, Shriver C, Hu H, Palazzo J, Bibbo M, Hyslop T, Nevalainen M, Pestell R, Fuchs S, Mitchell E, Rui H
JCO Precision Oncology 2023
JCO Precision Oncology 2023
PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
Dowell A, Munford H, Goel A, Gordon N, James N, Cheng K, Zeegers M, Ward D, Bryan R
Frontiers in Oncology 2021;11
Frontiers in Oncology 2021;11
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?
Solinas C, Aiello M, Rozali E, Lambertini M, Willard-Gallo K, Migliori E
Translational Oncology 2020;13(10):100811
Translational Oncology 2020;13(10):100811
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Zhang Y, Wang L, li y, Pan Y, Hu H, Li H, Luo X, Ye T, sun y, chen h, Wang R
OncoTargets and Therapy 2014
OncoTargets and Therapy 2014
No comments: Submit comment
No validations: Submit validation data